Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
A summary of the principal features of the 2017 Plan is included in the proxy
statement for the Annual Meeting, which we filed with the
Item 5.07. Submission of Matters to a Vote of Security Holders.
We held the Annual Meeting on
The matters considered and voted on by the stockholders at the Annual Meeting and the votes of the stockholders were as follows:
PROPOSAL 1
Stockholders voted as follows with respect to election of each of the director nominees identified in the Proxy Statement:
Nominee For Against Abstain Broker Non-Votes Cheryl R. Blanchard, Ph.D. 11,364,225 1,113,796 8,275 736,701 Glenn R. Larsen, Ph.D. 11,977,055 315,809 193,432 736,701
As a result of this vote, Drs. Blanchard and Larsen were elected as Class II directors to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
PROPOSAL 2
Stockholders voted as follows with respect to approval of the Amendment with respect to the 2017 Plan:
For Against Abstain Broker Non-Votes 10,078,047 2,252,365 155,884 736,701 PROPOSAL 3 Stockholders voted as follows with respect to ratification of the appointment ofDeloitte & Touche LLP as our independent registered public accounting firm for 2022: For Against Abstain Broker Non-Votes 13,126,419 81,275 15,303 - PROPOSAL 4
Stockholders voted, on an advisory basis, as follows with respect to compensation paid to our Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion set forth in the Proxy Statement:
For Against Abstain Broker Non-Votes 12,145,089 286,360 54,847 736,701
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. DescriptionAnika Therapeutics, Inc. 2017 Omnibus Incentive Plan (as amended 10.1† effectiveJune 8, 2022 ) Cover Page Interactive Data File (embedded within the Inline XBRL 104 document)
† Management contract or compensatory plan or arrangement.
© Edgar Online, source